HomeCompareWRTBF vs MRK

WRTBF vs MRK: Dividend Comparison 2026

WRTBF yields 1.80% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.3K in total portfolio value
10 years
WRTBF
WRTBF
● Live price
1.80%
Share price
$35.50
Annual div
$0.64
5Y div CAGR
-8.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$78.54
Full WRTBF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — WRTBF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWRTBFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WRTBF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WRTBF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WRTBF
Annual income on $10K today (after 15% tax)
$153.24/yr
After 10yr DRIP, annual income (after tax)
$66.76/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,529.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WRTBF + MRK for your $10,000?

WRTBF: 50%MRK: 50%
100% MRK50/50100% WRTBF
Portfolio after 10yr
$39.5K
Annual income
$5,096.16/yr
Blended yield
12.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WRTBF
No analyst data
Altman Z
3.8
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WRTBF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWRTBFMRK
Forward yield1.80%2.81%
Annual dividend / share$0.64$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-8.7%32.7%
Portfolio after 10y$21.4K$57.7K
Annual income after 10y$78.54$10,113.78
Total dividends collected$1.2K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WRTBF vs MRK ($10,000, DRIP)

YearWRTBF PortfolioWRTBF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,865$164.60$11,213$373.04$348.00MRK
2$11,778$152.59$12,667$512.06$889.00MRK
3$12,743$141.14$14,439$708.14$1.7KMRK
4$13,766$130.31$16,640$988.16$2.9KMRK
5$14,849$120.11$19,432$1,394.07$4.6KMRK
6$15,999$110.55$23,057$1,992.90$7.1KMRK
7$17,221$101.64$27,889$2,894.79$10.7KMRK
8$18,520$93.34$34,518$4,286.29$16.0KMRK
9$19,902$85.66$43,912$6,494.35$24.0KMRK
10$21,373$78.54$57,714$10,113.78$36.3KMRK

WRTBF vs MRK: Complete Analysis 2026

WRTBFStock

Wärtsilä Oyj Abp provides technologies and lifecycle solutions for the marine and energy markets worldwide. The company's marine power portfolio includes engines, propulsion systems, hybrid technology, and integrated powertrain systems; marine systems comprising products and lifecycle services related to the gas value chain, exhaust treatment, shaft line, underwater repair, and electrical integrations; voyage solutions consists of bridge infrastructure, cloud data services, decision support systems, and smart port solutions to enable shore-to-shore visibility, as well as builds end-to-end connected digital ecosystem for shipping; and decarbonization energy services include future-fuel enabled balancing power plants, hybrid solutions, energy storage, and optimization technology, such as the GEMS energy management platform. It provides power and propulsion products, such as electrical and power systems, engines and generating sets, propulsors and gears, and shaft line solutions; gas, ballast water management, freshwater generation, waste and wastewater treatment, and exhaust treatment solutions; and voyage and fleet optimization services comprising autonomy, simulation and training, fleet optimization and safety, integrated vessel control systems, port and traffic management, and dynamic positioning services. The company also offers spare parts and field services, technical support, maintenance and repair services, lifecycle upgrades and solutions, and training services. In addition, it provides products and solutions for energy storage, and engine and hybrid power plants. The company serves merchant vessels, gas carriers, cruise and ferry, navy, and special vessels segments; offshore installations and related industry vessels and land-based gas installations; and ship owners, shipyards, and ship management companies. Wärtsilä Oyj Abp was founded in 1834 and is headquartered in Helsinki, Finland.

Full WRTBF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this WRTBF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WRTBF vs SCHDWRTBF vs JEPIWRTBF vs OWRTBF vs KOWRTBF vs MAINWRTBF vs JNJWRTBF vs ABBVWRTBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.